Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kazuhiro Kajiyama"'
Autor:
Tomoaki Hasegawa, Maki Komamine, Chieko Ishiguro, Haruka Motomura, Kazuhiro Kajiyama, Takahiro Nonaka, Yuki Nakazato, Ryota Kimura, Harumi Maniwa, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background In the post-marketing stage, cases of hypocalcemia associated with bisphosphonate preparations (BPs) have been reported in patients with decreased kidney function, despite warning against use of BPs in such patients in the package
Externí odkaz:
https://doaj.org/article/3e54dbdc75b24830960cf6113254e277
Autor:
Yusuke Okada, Kazuhiro Kajiyama, Chieko Ishiguro, Takahiro Nonaka, Tomomi Komaki, Wataru Kuga, Noriyuki Komiyama, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama
Publikováno v:
Journal of Dermatological Treatment, Vol 35, Iss 1 (2024)
Background To evaluate the risk of neutropenia during treatment with anti-IL-23 antibodies in patients with psoriasis.Method We conducted an observational study with cohort design using MID-NET® in Japan. We identified patients with psoriasis who we
Externí odkaz:
https://doaj.org/article/16a7a73e849a4f40987bba19578c03fe
Autor:
Haruka Shida, Maki Komamine, Kazuhiro Kajiyama, Takashi Waki, Hotaka Maruyama, Yoshiaki Uyama
Publikováno v:
PLoS ONE, Vol 19, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/e181b4be21554b05b72ba6a782d4737c
Autor:
Takashi Waki, Yusuke Okada, Yuki Kinoshita, Kazuhiro Kajiyama, Chieko Ishiguro, Yuki Nakazato, Ryota Kimura, Harumi Maniwa, Naoya Horiuchi, Toyotaka Iguchi, Yoshiaki Uyama
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
IntroductionThis study was conducted to understand the impact of package insert (PI) revision in Japan on 18 June 2019 to allow metformin use for patients with moderately decreased kidney function (30 ≤ estimated glomerular filtration rate (eGFR)
Externí odkaz:
https://doaj.org/article/ae9ff6eb44584375b2892b3a5544ea25
Autor:
Sono Sawada, Kazuhiro Kajiyama, Haruka Shida, Ryota Kimura, Yuki Nakazato, Toyotaka Iguchi, Yukio Oniyama, Chieko Ishiguro, Yoshiaki Uyama
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 2, Pp 206-215 (2023)
Abstract In the present study, we aimed to investigate the association between urate‐lowering drugs and cardiovascular events, primarily focusing on the risk of febuxostat and topiroxostat when compared with allopurinol in Japan. We conducted an ob
Externí odkaz:
https://doaj.org/article/4fef8c49a4ba432e89f6551a1a6577a5
Autor:
Haruka Shida, Kazuhiro Kajiyama, Sono Sawada, Chieko Ishiguro, Mikiko Kubo, Ryota Kimura, Mai Hirano, Noriyuki Komiyama, Toyotaka Iguchi, Yukio Oniyama, Yoshiaki Uyama
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
The Pharmaceuticals and Medical Devices Agency (PMDA) has conducted many pharmacoepidemiological studies for postmarketing drug safety assessments based on real-world data from medical information databases. One of these databases is the National Dat
Externí odkaz:
https://doaj.org/article/ab7cb8b8c86647c585e7d163de6b27d1
Autor:
Yuki Kinoshita, Kazuhiro Kajiyama, Chieko Ishiguro, Takahiro Nonaka, Ryota Kimura, Yuki Kikuchi, Naoya Horiuchi, Toyotaka Iguchi, Yoshiaki Uyama
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:924-931
Autor:
Sono Sawada, Kazuhiro Kajiyama, Haruka Shida, Ryota Kimura, Yuki Nakazato, Toyotaka Iguchi, Yukio Oniyama, Chieko Ishiguro, Yoshiaki Uyama
Publikováno v:
Clinical and Translational Science. 16:206-215
In the present study, we aimed to investigate the association between urate-lowering drugs and cardiovascular events, primarily focusing on the risk of febuxostat and topiroxostat when compared with allopurinol in Japan. We conducted an observational
Autor:
Yoshiaki Uyama, Yukio Oniyama, Yuki Kubota, Chieko Ishiguro, Natsumi Kinoshita, Toyotaka Iguchi, Takashi Ando, Kazuhiro Kajiyama
Publikováno v:
Clinical Pharmacology and Therapeutics
Although several spontaneous case reports on the occurrence of thrombocytopenia in patients treated with human granulocyte colony-stimulating factor (G-CSF) preparations have been accumulated, its actual causality is still unclear. To investigate the
Publikováno v:
Pharmacoepidemiology and drug safetyREFERENCES. 28(9)
Purpose We evaluated the cardiovascular risk associated with dipeptidyl peptidase-4 inhibitors (DPP-4Is) as monotherapy compared with other antidiabetic drugs in Japan. Methods We conducted a nationwide cohort study involving 2 716 000 diabetes patie